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ABSTRACT Enteropathogenic Escherichia coli (EPEC) is an attaching and effacing (A/E) human pathogen that causes diarrhea
during acute infection, and it can also sustain asymptomatic colonization. A/E E. coli depletes host cell DNAmismatch repair
(MMR) proteins in colonic cell lines and has been detected in colorectal cancer (CRC) patients. However, until now, a direct link
between infection and host mutagenesis has not been fully demonstrated. Here we show that the EPEC-secreted effector protein
EspF is critical for complete EPEC-induced depletion of MMR proteins. The mechanism of EspF activity onMMR protein was
posttranscriptional and dependent on EspFmitochondrial targeting. EPEC infection also induced EspF-independent elevation
of host reactive oxygen species levels. Moreover, EPEC infection significantly increased spontaneous mutation frequency in host
cells, and this effect was dependent onmitochondrially targeted EspF. Taken together, these results support the hypothesis that
A/E E. coli can promote colorectal carcinogenesis in humans.
IMPORTANCE There is mounting evidence linking the gut microbiota with the induction of colorectal tumorigenesis. We previ-
ously described the downregulation of host cell mismatch repair (MMR) protein levels upon enteropathogenic Escherichia coli
(EPEC) infection and speculated that this depletion may lead to an ablated DNA repair system. In this work, we identify EspF, a
translocated EPEC effector protein, as one of the factors required for this phenotype and show that this effector protein must be
targeted to the mitochondria in order to exert its effect. Furthermore, we found that the impaired mismatch repair system result-
ing from EPEC infection led to the generation of spontaneous mutations within host DNA at a site of microsatellite instability, a
trait typical of colorectal tumors. Thus, this work provides a novel means by which enteric bacteria may promote colorectal car-
cinogenesis.
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Enteropathogenic Escherichia coli (EPEC) attaches intimately tointestinal epithelial cells and uses a type 3 secretion system
(T3SS) to translocate multiple effector proteins into the host cell
cytoplasm. Effectors induce cytoskeletal remodeling at the cell
surface, forming actin pedestals on which the bacteria sit (1).
EPEC effectors also induce a plethora of other host cellular
changes. Multiple studies analyzing colonic mucosa samples from
colorectal cancer (CRC) patients have demonstrated an associa-
tion between adherent E. coli strains and CRC (2–4). In addition,
evidence of a link between attaching and effacing (A/E) bacteria
and cancer has been provided by the murine pathogen Citrobacter
rodentium, which promotes tumorigenesis in Apcmin/ mice (5)
and facilitates chemically induced tumorigenesis (6). Whether the
association between A/E bacteria and cancer is causal remains to
be fully determined. The ability to modulate host protein expres-
sion raises the possibility that EPEC promotes oncogenic path-
ways in colonic epithelial cells. In support of this hypothesis, we
recently described the ability of EPEC to deplete mismatch repair
(MMR) proteins MSH2 and MLH1 in cultured colonic cells in a
T3SS-dependent manner (2).
The MMR system corrects DNA base pair mismatches and
insertion/deletion loops (IDL) caused by replication errors or
DNA damaging agents. In mammalian cells, this system is orches-
trated by protein heterodimers, termed the MutS and MutL com-
plexes. MutS is composed of the MSH2 and MSH6 proteins and
represents the most abundant mismatch binding factor, while
MutS is composed of MSH2 and MSH3. The MutL complexes
contain MLH1 heterodimerized with either PMS2 (MutL),
PMS3 (MutL), or MLH3 (MutL). It is hypothesized that the
MutS complexes recognize DNA base pair mismatches or IDL and
then recruit MutL. A MutS/MutL conformation switch then re-
sults in the activation of exonuclease DNA degradation and even-
tual repair by DNA polymerase  (reviewed in reference 7). Hence,
MMR is ablated by loss of either one of the critical proteins (MSH2
or MLH1); this is exemplified by the rapid accumulation of spon-
taneous somatic mutations throughout the genome, particularly
in long repeated sequences of 1 to 4 nucleotides, termed microsat-
ellites, in the absence of either protein (8, 9). In addition to causing
microsatellite instability (MSI), MMR disruption enhances so-
matic mutation of tumor suppressor genes such as Apc and Tp53,
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which are mutated in the majority of CRC (10). Heritable MMR
gene mutations are the cause of hereditary nonpolyposis colorec-
tal cancer (HNPCC) (Lynch syndrome) (11).
MMR gene silencing, either by somatic mutation or promoter
hypermethylation, also contributes to sporadic CRC development
(12, 13). However, a significant proportion of tumors display MSI
without accompanying MMR gene mutation or hypermethyl-
ation (14), suggesting that alternative causes of MMR disruption
exist. In the present study, we investigated the mechanism by
which EPEC depletes MMR proteins and sought to establish
whether this effect increases host mutagenesis.
RESULTS
EPEC depletes MMR proteins posttranscriptionally. We previ-
ously reported that infection with wild-type EPEC strain E2348/69
induced a marked depletion of MSH2 and MLH1 protein levels in
HT29 and SW480 colon cells. Given that promoter hypermethyl-
ation causes transcriptional silencing of MLH1, we speculated that
MMR protein downregulation resulted from decreased transcrip-
tion (2). Here we confirm that wild-type EPEC causes a dramatic
depletion of MSH2 and MLH1 in HT29 cells after 4 to 5 h (Fig. 1A
and B). Analysis of MSH6 levels also confirmed decreased expres-
sion of this protein at 6 h postinfection (see Fig. S1 in the supple-
mental material). As MSH6 stability is dependent on MSH2 ex-
pression (15), depletion of MSH6 may be a direct effect of
infection or secondary to MSH2 depletion. Because of the impor-
tance of MSH2 and MLH1 for overall MMR competence, we fo-
cused our analysis on these two proteins. Treatment with genta-
micin to kill EPEC after 6 h of infection fully restored MSH2 and
MLH1 expression (Fig. 1A and B). Despite the dramatic drop in
protein levels, quantitative real-time PCR (qRT-PCR) revealed
that transcription of MSH2 and MLH1 was in fact elevated in
response to infection (Fig. 1C). Elevated transcription corre-
sponded with increased amounts of MSH2 and MLH1 protein in
the postinfection period (Fig. 1B). We therefore conclude that loss
of MMR proteins does not occur due to lower transcription. In
contrast, the host cell appears to respond to EPEC infection by a
compensatory increase in MMR gene transcription.
Adherence does not correlate with MMR protein depletion.
We showed previously that a mutant of EPEC E2348/69 lacking a
crucial component of the T3SS (espBmutant) was unable to fully
deplete MSH2 and MLH1, suggesting that MMR protein deple-
tion is dependent either on intimate attachment itself or on an
effector protein(s) translocated during intimate attachment (2).
To explore this hypothesis, we infected HT29 cells with a panel of
E2348/69 T3SS effector and related mutants.
Western blots revealed that effector mutants of EPEC
E2348/69 had different effects on MSH2 (Fig. 2A) and MLH1
protein levels (data not shown). However, microscopic examina-
tion revealed that the mutants also had different adhesion prop-
erties. This made it difficult to discern whether specific effector
proteins were causing the changes in host MMR protein. For this
reason, we quantified the adherent and nonadherent bacteria in
cocultures after 5 h and quantified MSH2 and MLH1 expression
in the same cultures to determine the relationship between the
numbers of adherent bacteria and the levels of MSH2 and MLH1
protein. Interestingly, for MSH2, we observed a nonlinear rela-
tionship, indicating a role for effector proteins in modulating the
levels of this protein (Fig. 2B). Wild-type EPEC had the highest
adherence levels. The espF and map strains were the only mu-
tants that adhered at levels comparable to, albeit lower than, the
levels of the wild type, with adherence of the other mutants being
markedly lower (Fig. 2B; see Fig. S2 in the supplemental material).
FIG 1 EPEC strain E2348/69 induces MSH2 and MLH1 protein depletion
that is not due to transcriptional silencing. (A) Western blot showing MSH2
and MLH1 expression in HT29 cells cocultured with E2348/69 (wild-type
EPEC) for up to 6 h. HT29 cells that were allowed to recover from infection
were initially cocultured with strain E2348/69 for 6 h, then washed, and treated
with antibiotics for up to 72 h postinfection. (B) MSH2 and MLH1 expression
were quantitatively analyzed by secondary antibody infrared absorption anal-
ysis (Li-Cor Odyssey system) and corrected for loading using actin staining
intensity. (C) Quantitative RT-PCR for MSH2 and MLH1 expression was per-
formed on total mRNA extracts from the same cell populations used for pro-
tein analysis. Data are from three independent experiments, and values are
means plus standard errors of the means (SEM) (error bars). The statistical
significance of values compared to the value for control uninfected cells was
assessed by Student’s t test and indicated as follows: *, P 0.05; **, P 0.01;
***, P 0.001.
Maddocks et al.
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It was clear that the number of adherent bacteria per cell did not
predict the effect of infection on MMR protein expression. De-
spite having low adherence, the espH mutant strain for example
caused approximately 60% depletion of MSH2 levels (Fig. 2B),
excluding this effector as a major contributor to MMR protein
reduction. In contrast, the tir mutant strain, which showed a
level of adherence similar to that of the espH mutant, actually
caused increased MSH2 expression. Furthermore, the mutant
strains with the highest levels of adherence, the espF and map
mutants, induced only a modest (~25%) decrease in MSH2 ex-
pression (Fig. 2B). MLH1 was more sensitive to depletion than
MSH2, with every strain inducing a large depletion in MLH1,
ranging from 60 to 100% (Fig. S2).
Predictably, the mutant strains with low numbers of adherent
bacteria (espB, espZ, espH, espG, and tir mutants) dis-
played high levels of nonadherent bacteria (Fig. 2C). Consistent
with this trend, the wild-type strain and the map and espF
mutant strains had the lowest numbers of nonadherent bacteria.
There was no obvious correlation between the levels of nonadher-
ent bacteria and MMR protein expression. Interestingly, while the
espF strain had the highest adherence levels of all the mutants;
the amounts of MSH2 were relatively preserved compared with
wild-type infection (71% 5.4% versus 25% 4.1% [Fig. 2B]).
This result suggested that the locus of enterocyte effacement (LEE)
effector EspF might play a major role in the EPEC infection-
induced depletion of MSH2.
Complete host MMR protein depletion requires transloca-
tion and mitochondrial targeting of EspF. To further establish
the importance of EspF in depleting host MMR protein, we inves-
tigated the pathway involved. T3SS effectors influence host cell
biology by targeting specific organelles and by regulating the level
and activity of host cell proteins. EspF has an N-terminal sequence
that targets the mitochondria and the nucleolus, and EspF also
localizes to the host plasma membrane (16). Here, we examined
the role of EspF mitochondrial targeting using a version of the
espF gene that encodes a Leu-to-Glu amino acid substitution at
position 16 (espFL16E); the resulting protein is inhibited in its abil-
ity to localize to mitochondria (17).
HT29 and SW480 cells were cocultured with wild-type EPEC
(E2348/69), espF mutant, espF mutant complemented with
plasmid-encoded espF (espF pespF), and espF mutant comple-
mented with plasmid-encoded espFL16E (espF pespFL16E). As ex-
pected, espF induced only a modest decrease in MSH2 and
MLH1 compared to EPEC E2348/69 (Fig. 3A to C). Complemen-
tation of theespF mutant with wild-type EspF restored its ability
to deplete MMR proteins, further validating the role of EspF in
depleting MMR protein. However, complementation with
EspFL16E that translocates into the host cytoplasm but is deficient
in mitochondrial targeting did not restore the ability to deplete
host MMR proteins (P  0.001 compared with the espF pespF
strain for both MSH2 and MLH1 from infected HT29 cells). EspF
is rapidly targeted to the mitochondria (within 30 min), causing a
change in mitochondrial membrane potential (m) as early as
1 h postinfection (18, 19). To determine whether MMR protein
depletion was solely due to mitochondrial disruption by the effec-
tor, we assessed the levels of MMR proteins following treat-
ment with an uncoupling compound that causes mitochondrial
membrane depolarization, carbonyl cyanide m-chlorophenyl-
hydrazone (CCCP). Cells were incubated for 7 h with increasing
concentrations of CCCP from 1 M to 50 M, concentrations
known to cause total loss of m within 1 h (20). Alterations to
the mitochondria caused by CCCP failed to decrease the levels of
MSH2 or MLH1 at any of the concentrations tested (see Fig. S3 in
the supplemental material), demonstrating that loss of m is
unlikely to be a mechanism by which EspF influences MMR pro-
tein expression.
Mitochondria are a potential source of cellular reactive oxygen
FIG 2 EPEC LEE effector mutants have differing abilities to adhere to HT29
cells and differing effects on MSH2 and MLH1 expression. (A) Western blot
showing MSH2 expression in HT29 cells cocultured with EPEC strain E2348/
69, effector protein mutants of E2348/69, and the espA mutant (which is
incapable of effector protein translocation) for 5 h. (B) HT29 cells were cocul-
tured with EPEC E2348/69 (the wild-type [WT] strain), effector protein mu-
tants of E2348/69, and theespA mutant for 5 h, and bacterial attachment and
MSH2 levels were quantified and plotted against one another. (C) Aliquots of
the infection supernatant medium were diluted and spread onto agar plates to
count nonadherent bacteria. The protein levels of MSH2 were plotted against
the CFU of bacteria in the supernatant. Each experiment was repeated at least
three times, and values are means (indicated by the markers)  SEM (error
bars).
EPEC EspF and MMR
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species (ROS) (21). On the basis of evidence that oxidative stress
depletes MMR protein levels in mammalian cells (22), we hypoth-
esized that mitochondrial targeting of EspF might trigger elevated
ROS levels, causing MMR protein depletion. To test whether the
time scale and magnitude of MMR depletion caused by oxidative
stress were comparable to EPEC infection, we treated cells with
hydrogen peroxide (H2O2). H2O2 caused MSH2 and MLH1 pro-
tein depletion, which was similar in magnitude to that caused by
E2348/69 (particularly in SW480 cells) over the same time course
(Fig. 3A to C).
EPEC infection causes increased ROS levels in host cells in-
dependently of EspF. To determine whether EPEC infection in-
duced a significant increase in ROS, cells were subjected to an
infection time course and analyzed for ROS levels by flow cytom-
etry (Fig. 4A). To assess the dependence of ROS elevation on EspF,
the panel of EspF mutants was tested. Increased ROS levels were
detected after 3 h of infection for all strains tested (Fig. 4B). EPEC
infection induced a 4.1-fold increase in ROS at 5 h compared with
uninfected cells. While the highest ROS levels were observed for
the espF pespF strain (4.9-fold increase after 5 h), this was fol-
lowed by the espF strain (4.7-fold increase after 5 h), indicating
that ROS levels were not dependent on EspF. In addition, there
was no significant difference between the espF pespF and espF
pespFL16E strains, indicating that EspF mitochondrial targeting
was not involved in ROS induction. Cells infected with the escN
mutant (which cannot assemble a functional T3SS) displayed the
lowest levels of ROS (3.6-fold increase after 5 h), but this value was
not significantly different from the value for wild-type EPEC
(Fig. 4B). Together, these results indicate that EPEC infection in-
duced a significant increase in host cell ROS. However, this ROS
increase was independent of T3S, and therefore does not explain
the role of EspF in depleting MMR proteins.
EPEC infection increases mutation frequency at a site of mi-
crosatellite instability. The failure to express functional DNA
MMR proteins causes increased somatic mutation rate in vivo and
strongly promotes colorectal carcinogenesis. Microsatellite DNA
sequences are particularly susceptible to mutations normally cor-
rected by the MMR system (9). MMR dysfunction therefore leads
to accumulation of mutations in microsatellite sequences (and
elsewhere in the genome), a phenomenon termed microsatellite
instability (MSI). Interestingly, oxidative stress has been shown to
enhance mutations in an MSI sequence within colonic cells defi-
cient in MMR protein expression (23). With the knowledge that
EPEC infection depletes MMR protein concomitant with elevated
ROS levels, we sought to determine the functional consequences
of these effects on host mutation frequency. To achieve this goal,
we used a method that allows direct selection of cultured cells that
have failed to repair spontaneously generated DNA mutations
(24).
SW480 cells were stably transfected with a fusion gene contain-
ing a microsatellite sequence with 12 consecutive cytosine residues
[(C)12 TKBSD] or a control fusion gene without the microsatellite
sequence (thymidine kinase-blasticidin deaminase [TKBSD]).
The (C)12 sequence is in frame with respect to the TK gene con-
ferring ganciclovir sensitivity. Ganciclovir resistance results when
a frameshift mutation occurs and is not repaired. The cells were
infected for 6 h with EPEC strain E2348/69, espF mutant, espF
pespF strain, orespF pespFL16E mutant and subjected to ganciclo-
vir selection. As expected, a low level of cell survival was observed
in the TKBSD cells (Fig. 5) and in the uninfected (C)12 TKBSD
cells, indicating competent DNA repair in these cells (Fig. 5). In
marked contrast, EPEC infection induced a significant increase in
mutation at the (C)12 site. Furthermore, this increase was EspF
dependent, as determined by the significant decrease in mutation
observed with theespF strain versus the wild type. Restoration of
EspF expression in theespF strain restored the wild-type pheno-
type; however, complementation of espF with EspFL16E did not,
FIG 3 MMR depletion was dependent on mitochondrial targeting of EspF.
(A) EspF-dependent depletion of MSH2 and MLH1 proteins in HT29 cells
(left) and SW480 cells (right) was assessed by Western blotting following 5 h
infection with EPEC strain E2348/69, espF mutant, espF mutant comple-
mented with plasmid-encoded espF (espF pespF), or espF mutant comple-
mented with plasmid-encoded espFL16E (espF pespFL16E). Cells were also
treated with hydrogen peroxide (0.03% [vol/vol] H2O2) to induce oxidative
stress. The black arrow indicates a cross-reactive band. (B and C) The expres-
sion of MSH2 and MLH1 in HT29 (B) and SW480 (C) cells were quantified
using the Odyssey infrared imaging system and corrected for actin loading.
Each experiment was repeated at least three times, and values are means (in-
dicated by the markers) plus SEM (error bars). The statistical significance of
values compared to the value for control uninfected cells was assessed by t test
and indicated as follows: *, P 0.01; **, P 0.001.
Maddocks et al.
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demonstrating that the effect was dependent on mitochondrial
targeting.
DISCUSSION
In the present study, we confirmed the prior observation that
EPEC depletes MMR protein in colonic epithelial cells. We estab-
lished that this effect did not occur via transcriptional silencing, as
host cells responded to EPEC infection with increased MSH2 and
MLH1 transcription, suggesting a possible compensatory re-
sponse. This result demonstrates that MMR protein depletion is
an EPEC-directed effect that the host cells attempt to counteract.
Given these results and the rapidity of the effect, it seems likely that
infection modulates MMR protein expression via a posttransla-
tion mechanism. We demonstrated that the EPEC-secreted effec-
tor EspF was required for complete EPEC-induced MMR protein
depletion and that the mitochondrial targeting motif of EspF was
essential for this effect.
Oxidative stress is reported to cause MMR protein depletion
(22), and we successfully validated this mechanism in our model
using H2O2. We hypothesized that mitochondrial targeting of
EspF might specifically enhance ROS generation in host cells and
that elevated ROS levels would explain the enhanced ability of
EspF-expressing strains to deplete MMR proteins. Contrary to
our expectations, EspF-competent strains did not have an en-
hanced ability to promote host cell ROS generation. All of the
strains we tested caused elevated ROS levels, suggesting that this
effect does not require the T3SS. While ROS are not the mecha-
nism by which EspF specifically depletes MMR protein, they may
explain the residual MMR protein depletion caused by almost all
strains tested. Intracellular ROS can cause oxidative modifications
to both proteins and DNA (25, 26). The increased sensitivity to
EPEC infection of MLH1 compared to MSH2 was a consistent
trend in our experiments. Analysis of MLH1 reveals that it con-
tains an oxidation susceptible motif (27) not present in MSH2.
Furthermore, H2O2 caused a more marked depletion of MLH1
than MSH2. On the basis of this evidence, we speculate that
infection-induced ROS contributes to MLH1 depletion by EPEC
but that EspF is required for maximal depletion of MSH2, which is
more resistant to ROS than MLH1 is.
While the exact mechanism by which EspF depletes MMR pro-
tein remains to be fully elucidated, the functional consequences of
this effect were dramatic: we are the first to report that EPEC
infection causes increased mutation frequency in host cells and
that these mutations are substantially dependent on translocation
and mitochondrial targeting of EspF. Interestingly, the only other
EPEC effector mutant that displayed properties similar to those of
theespF strain was themapmutant. Like theespFmutant, the
map mutant showed high adherence and inability to induce
complete MMR protein depletion. Map is also targeted to host
mitochondria where it too causes a loss ofm (28). However, we
found no evidence that loss of m causes depletion of MMR
proteins. In the future, it would be interesting to investigate the
properties of a espF map double mutant or to ectopically ex-
press single EPEC effectors in host cells to help delineate the spe-
cific contributions of each effector.
Several other previously described activities of EPEC effectors
FIG 4 EPEC infection induces an increase in ROS. (A) HT29 cells were infected with EPEC strain E2348/69, and the levels of ROS were determined by flow
cytometry over time. (B) Infection of HT29 cells with EPEC strain E2348/69, espF mutant, espF pespF strain, espF pespFL16E strain, or escN mutant all
resulted in elevated ROS levels after 3 h of infection. Data are from three independent experiments. The data points in panel B are means SEM (error bars).
FIG 5 The EPEC effector EspF increases mutation frequency at a microsat-
ellite DNA site. SW480 cells transfected with a reporter fusion gene containing
a (C)12 microsatellite sequence were subjected to infection with EPEC strain
E2348/69, espF mutant, espF pespF strain, or espF pespFL16E strain (black
bars). Cells transfected with the fusion gene without the microsatellite se-
quence acted as a negative control (white bars). Examples of each of the
(C)12TKBSD cell plates are displayed below their respective bars in the graph.
Data are from six experiments, and values are means plus SEM. The statistical
significance of values was assessed by t test and indicated as follows: *,P 0.05;
**, P 0.005; ***, P 0.001.
EPEC EspF and MMR
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also have the potential to promote cancer; in particular, infection
can modulate host cell survival. EPEC effectors NleH1 and NleH2
can block apoptosis (29). EPEC-induced epidermal growth factor
receptor (EGFR) activation also enhances the survival of infected
cells; activated EGFR signaling is a feature of many cancers (30).
Inhibition of host cell death also provides a rationale for EPEC
effector-induced MMR disruption. Oxidative stress causes a vari-
ety of DNA lesions that are detected and repaired by the MMR
pathway. However, when MMR proteins encounter high levels of
DNA damage, they invoke a proapoptotic response via p53 to
eliminate the damaged cell (31). By causing MMR protein deple-
tion, EPEC could prevent the apoptotic response that may other-
wise be triggered by the effects of EPEC-induced ROS on host
DNA.
EPEC infection is a leading cause of infantile diarrhea in the
developing world. In developed countries, EPEC is no longer con-
sidered a serious public health problem and is not routinely
sought in clinical laboratories. Contemporary epidemiological
data for EPEC in adults is therefore lacking. However, studies in
Europe and Australia reveal that EPEC is carried by ~2.5 to 10% of
healthy children (32, 33). Independent studies using tissue sam-
ples from adults with CRC demonstrate an association between
mucosally adherent E. coli and CRC (2–4). Immunohistochemical
analysis of human colonic mucosa cocultured with EPEC demon-
strates that EPEC can enter colonic crypts and attach to epithelial
cells in the proliferative compartment (2). The ability to asymp-
tomatically colonize humans and to interact with proliferative
cells in the crypt niche provides the biological context for EPEC to
influence tumorigenesis. That EPEC can elevate ROS, suppress
DNA repair, and increase mutation frequency in host cells pro-
vides a compelling mechanism by which these bacteria could pro-
mote CRC development.
CRC is a leading cause of cancer-related death worldwide. The
majority of cases occur due to somatic mutations rather than in-
herited mutations, but the exact causes of the somatic mutations
that initiate and drive sporadic CRC remain poorly defined. The
importance of gene-environment interactions in causing CRC has
been highlighted; however, conclusive research in this area is lack-
ing (34). Mounting evidence suggests a causal link between bac-
terial infection and CRC and the potential contribution of patho-
genic bacteria to CRC development has been noted (5, 6, 35).
Our data suggest that EPEC infection could promote somatic
mutations (particularly in microsatellite DNA sequences) in co-
lonic epithelium that does not feature genetic or epigenetic MMR
silencing. Tumors developing in this way would be likely to show
signs of MSI and critically, mutations in MSI sequences within
oncogenes/tumor suppressor genes. Frameshift mutations in the
tumor suppressor APC have been detected in tumors that do not
display MMR gene mutation or hypermethylation (36). Many
colorectal tumors display MSI that is not accompanied by MMR
gene mutations or hypermethylation. The concept that alternative
mechanisms account for MMR inactivation in a significant pro-
portion of colorectal tumors is therefore well established (22, 23,
36).
Our findings provide a strong rationale for further investiga-
tion of A/E E. coli, particularly EPEC, in the context of colorectal
carcinogenesis. Epidemiological studies in humans will be critical
to establish a causal relationship. However, standard stool sample
testing may not be an effective means to identify A/E bacteria due
to their probable low levels in asymptomatic carriers. For this
reason, we suggest analysis of tissue samples, e.g., biopsy samples
or tissue samples removed during colorectal surgery.
MATERIALS AND METHODS
Bacterial strains andplasmids.Bacterial strains and plasmids used in this
study are listed in Table 1. Prior to infection, EPEC bacteria were cultured
overnight in LB broth and appropriate antibiotics at 37°C. Overnight
cultures were then diluted 1:50 in Dulbecco modified Eagle medium
(DMEM) with nutrient mixture F-12 (DMEM/F12) with 5% fetal bovine
serum (FBS) and maintained at 37°C for 1 h without agitation to activate
the bacteria.
Tissue culture. Human colorectal cancer cell lines HT29 and SW480
were obtained from the American Type Culture Collection (ATCC) (Ma-
nassas, VA). Cells were maintained at 37°C with 5% CO2 in DMEM/F12
medium (Gibco Invitrogen, NY) supplemented with 10% fetal bovine
serum (Benchmark FBS; Gemini Bio-Products, CA). As the FBS brand/lot
can have a considerable effect on bacterial growth rate (2), a single lot
number of FBS was used for each set of experiments to provide consis-
tency. For in vitro infections, cells were seeded in 12-well or 24-well plates
(Corning, NY) and grown to a confluent monolayer.
Isolation of stable transfectants. pcDNA3-TKBSD and pcDNA3-
(C)12TKBSD were prepared as previously described (24) and used to
transfect SW480 cells using the Xfect transfection reagent (Clontech, Palo
Alto, CA). Two days posttransfection, selection was initiated by the addi-
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Mutation(s) Gene carried on plasmid Reference
Bacterial strainsa
E2348/69 (EPEC 0127:H7) 37
CVD452 escN 38
UMD872 espA 39
UMD864 espB 40
UMD874 espF 41
espG orf3 mutant espG (espG1 espG2) 42
espH mutant espH 43
MK34 espZ 44
JAC719 tir 45
SE882 map 46
Plasmids
pJN61 espF 19
pJN61L16E espFL16E This study
pcDNA3-TKBSD 24
pcDNA3-(C)12TKBSD 24
a All bacterial strains were derived from EPEC strain E2348/69.
Maddocks et al.
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tion of 10g/ml blasticidin S (EMD Millipore Corp., Billerica, MA). After
2 to 3 weeks, stable clones were isolated and additionally propagated with
100 g/ml blasticidin S. To ensure thymidine kinase expression, clones
were also subjected to ganciclovir (Sigma-Aldrich, St. Louis, MO) treat-
ment (30 M), and sensitivity was confirmed prior to experimentation.
In vitro coculture. Activated bacterial cultures were added to conflu-
ent cell monolayers at a multiplicity of infection (MOI) of 30:1. After
variable periods, cells were grown with 200 g/ml gentamicin, 200 IU/ml
penicillin, and 200 g/ml streptomycin to kill bacteria and allow the cells
to recover after infection. Whole-cell protein extracts were prepared from
cell pellets after lysis in 1% Triton X-100 (in phosphate-buffered saline
[PBS]) or radioimmunoprecipitation assay (RIPA) buffer, supplemented
with Complete protease inhibitor cocktail (Roche Diagnostics, Germany).
For qRT-PCR analysis, RNA was extracted from cell pellets using an
RNeasy mini kit (Qiagen) according to the manufacturer’s instructions.
Quantification of mutation frequency. To determine the frequency
of mutation within the (C)12 microsatellite instability site of the TKBSD
fusion gene, transfected cells we re infected for 6 h in DMEM/F12 medium
containing 5% FBS. After infection, the cells were cultured for 24 h in
DMEM/F12 medium containing 10% FBS, 100 IU/ml penicillin, and
100 g/ml streptomycin (complete DMEM [cDMEM]) and 200 g/ml
gentamicin (Invitrogen) and cultured an additional 24 h with cDMEM
supplemented with 100 g/ml gentamicin. Forty-eight hours postinfec-
tion, infected and control uninfected cells were cultured in cDMEM con-
taining 10 g/ml gentamicin with or without 30 M ganciclovir. After
7 days, total cell survival was calculated for the cells that did not receive
ganciclovir selection. The ganciclovir selection medium was replaced ev-
ery second day, and selection was continued for 14 days. After selection,
the cells in petri dishes were fixed with 4% formaldehyde and stained with
0.1% crystal violet (Sigma-Aldrich), and the numbers of colonies were
counted. The numbers of colonies were determined as a ratio of the cell
survival. Cells transfected with TKBSD were subjected to the same treat-
ment and acted as negative controls for the acquisition of mutations.
Western blotting. Whole-cell protein extracts were resolved through
precast 4 to 12% gradient Novex-NuPAGE gels (Invitrogen) and trans-
ferred to Immobilon-FL membranes (Millipore, MA). Blots were probed
with mouse anti-MSH2 (Ab-2) (clone FE11) (diluted 1:500) (EMD Bio-
sciences), mouse anti-MLH1 (diluted 1:1,000) (BD Biosciences, CA), and
rabbit anti-beta-actin AC-15 (diluted 1:5,000) (Sigma-Aldrich) primary
antibodies. IRDye 680- and IRDye 800-conjugated secondary antibodies
diluted 1:15,000 (Li-Cor Biosciences, NE) were then applied. Infrared
signals were detected and quantified using the Odyssey imaging system
(Li-Cor Biosciences).
qRT-PCR. Quantitative real-time PCR (qRT-PCR) reactions were
performed using Stratagene brilliant II SYBR green QRT-PCR (quantita-
tive reverse transcription-PCR) master mix with low ROX dye (Agilent
Technologies, CA) in a Stratagene Mx3005P instrument (Agilent Tech-
nologies, CA). The following primers were used: MSH2 forward, 5=-CAG-
TATATTGGAGAATCGCA; MSH2 reverse, 5=-AGGGCATTT-
GTTTCACC; MLH1 forward, 5=-GATTACCCCTTCTGATTGACA;
MLH1 reverse, 5=-ACTGAGGCTTTCAAAACA; GAPDH forward
(GAPDH stands for glyceraldehyde-3-phosphate dehydrogenase), 5=-
CGGAGTCAACGGATTGGTCGTAT; and GAPDH reverse, 5=-
AGCCTTCTCCATGGTGGTGAAGAC.
Flow cytometry. After infection, the cells were resuspended in PBS
containing the cell-permeant ROS indicator dye CM-H2DCFDA [5- (and
6-)-chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl es-
ter] (10 M) (Invitrogen) and incubated with the probe for 30 min at
37°C in a 5% CO2 incubator. Oxidation of the probe resulted in a deacety-
lated fluorescent product that was detected using a BD LSR II flow cytom-
eter (BD Biosciences). The relative amounts of ROS were determined by
geometric mean fluorescence intensity (MFI).
SUPPLEMENTAL MATERIAL
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Figure S1, TIF file, 1.1 MB.
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